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Dear Editor,
We read with interest Dr. Laffenêtre [1] current concept
review article, ‘‘Osteochondral lesions of the talus: Current
concept’’ (Epub ahead of print, 2010 July 14). It provides
a detailed and useful description of treatment options for
osteochondral talar lesions, with considerations for decision
making.
The author states that ‘‘arthroscopy appears to be the
most effective procedure for lesions smaller than 1 cm2’’,
refering to articles in which no distinction is made between
lesion size and outcome [2—5]. Furthermore, the author
states that ‘‘larger lesions (> 1 cm) should be ﬁlled, either
with cancellous bone or with an osteochondral graft or using
autogenous chondrocyte implantation’’. We disagree with
the author concerning the cutoff point of 1 cm2.
Zengerink et al. [6], in 2010, reported in a system-
atic review of treatment strategies for osteochondral talar
lesions, a mean success rate of 85% after debridement and
bone marrow stimulation including lesions up to 1.5 cm in
size. For autogenous chondrocyte implantationt, cancellous
bone graft, and osteochondral graft for large lesions, a mean
succes rate of 76%, 61%, and 87% was reported, respectively
[6]. In different current concepts reviews [7—9], debride-
ment and bone marrow stimulation is recommended for
primary lesions with a diameter less than 1.5 cm or a surface
area less than 1.5 cm [10]. A cancellous bone graft, osteo-
chondral graft or autogenous chondrocyte implantation is
recommended for secondary lesions or lesions with a diam-
eter greater than 1.5 cm. Han et al. [11], in 2006, conﬁrmed
that good clinical and radiographic results are obtained after
arthroscopic debridement and bone marrow stimulation for
lesions up to 1.5 cm in size, also in the presence of sub-
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doi:10.1016/j.otsr.2011.03.014hondral cysts. Recently, a cutoff point of a defect area
f approximately 1.5 cm2 was determined on 120 ankles as
risk of clinical failure of the arthroscopic bone marrow
timulation techniques [12].
Looking at the currently best available evidence
6,10—12], it is clear that treatment with debridement and
one marrow stimulation for isolated talar lesions is the
rimary treatment of choice for lesions of up to 15mm
n diameter. At this time, alternative treatment options
re mainly indicated for secondary and large lesions. Their
ffectiveness needs to be evaluated in larger series with
ong-term results.
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